See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.44▲ 3.99%
← SLBEN page
XStocksXray
Market X-Ray report · 23 October 2026

Benfica (SLBEN)

Euronext Lisbon · Portugal · prices in EUR · close of 23 Oct 2026

Key indicators

Last closeEUR 6.500
52-week range5.780 – 8.280
Return, 1 month / 3 months−3.3% / −3.3%
Return, 1 year / 3 years+3.5% / +98.8%
TrendBelow its 200-day average
RSI (14)42
Volatility (1 year)31.2%
Worst drawdown (1 year)-23.3%
Average daily value traded0.02M EUR
Dividend yield–

Market X-Ray price-based

43/ 100 · High confidence · ahead of 34% of stocks on this exchange
Trend34
Momentum54
Stability (higher is calmer)38
Liquidity47
Income–

Five-year price chart navy: price · brown: 200-day average

2.293.845.396.948.492021-112023-022024-052025-082026-10

About the company

Benfica is a Portuguese sports club based in Lisbon whose main activity is professional football. The club fields a senior team that plays in the Portuguese league and in European club competitions, and it also runs youth teams that train and develop young players. Alongside football, it operates other sports sections, and it serves its members and supporters through the club structure and its stadium.

The shares are listed on the Euronext Lisbon in Portugal under the code SLBEN, and the price on this page is in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Benfica (SLBEN) trades on the Euronext Lisbon in Portugal. It last closed at EUR 6.500 on 23 October 2026.

Its price-based Market X-Ray is 43 out of 100 (a weak price profile), ranking 24 of 36 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 3.5% and over the last three months it fell 3.3%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Benfica (SLBEN)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Lisbon

Lens and metricValueScoreReading
Trend34 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-4.1%
From 52-week high-20.3%
Momentum54 · FairTypical recent returns for this exchange.
3-month return-3.3%
6-month return0.6%
12-month return, skipping the last month7.0%
Stability (higher is calmer)38 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)31.2%
Worst drawdown, 1 year (smaller is calmer)-23.3%
Liquidity47 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.02M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−2.7%
1 month−3.3%
3 months−3.3%
6 months+0.6%
1 year+3.5%
3 years+98.8%
5 years+18.6%

Signals

50-day / 200-day average6.644 / 6.779
Golden / death cross (60 days)Death, 30 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.148

Technical summary

DailyStrongly bearish2 bullish · 2 neutral · 12 bearish
WeeklyBearish4 bullish · 1 neutral · 7 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Lisbon; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026